These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8188284)

  • 1. Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint.
    Boultwood J; Fidler C; Lewis S; Kelly S; Sheridan H; Littlewood TJ; Buckle VJ; Wainscoat JS
    Genomics; 1994 Feb; 19(3):425-32. PubMed ID: 8188284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the 5q- breakpoint in an acute nonlymphocytic leukemia patient using pulsed-field gel electrophoresis.
    Thornton DE; Theil K; Payson R; Balcerzak SP; Chiu IM
    Am J Med Genet; 1991 Dec; 41(4):557-65. PubMed ID: 1723247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel genes mapping to the critical region of the 5q- syndrome.
    Boultwood J; Fidler C; Soularue P; Strickson AJ; Kostrzewa M; Jaju RJ; Cotter FE; Fairweather N; Monaco AP; Müller U; Lovett M; Jabs EW; Auffray C; Wainscoat JS
    Genomics; 1997 Oct; 45(1):88-96. PubMed ID: 9339364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletions of chromosome 5 in malignant myeloid disorders.
    Le Beau MM
    Cancer Surv; 1992; 15():143-59. PubMed ID: 1451109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A physical map of 15 loci on human chromosome 5q23-q33 by two-color fluorescence in situ hybridization.
    Saltman DL; Dolganov GM; Warrington JA; Wasmuth JJ; Lovett M
    Genomics; 1993 Jun; 16(3):726-32. PubMed ID: 8325647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription mapping of the 5q- syndrome critical region: cloning of two novel genes and sequencing, expression, and mapping of a further six novel cDNAs.
    Boultwood J; Fidler C; Strickson AJ; Watkins F; Kostrzewa M; Jaju RJ; Müller U; Wainscoat JS
    Genomics; 2000 May; 66(1):26-34. PubMed ID: 10843801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
    Boultwood J; Pellagatti A; Cattan H; Lawrie CH; Giagounidis A; Malcovati L; Della Porta MG; Jädersten M; Killick S; Fidler C; Cazzola M; Hellström-Lindberg E; Wainscoat JS
    Br J Haematol; 2007 Nov; 139(4):578-89. PubMed ID: 17916100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5q-: pathogenetic importance of the common deleted region and clinical consequences of the entire deleted segment.
    Pedersen B
    Anticancer Res; 1993; 13(5C):1913-6. PubMed ID: 8267400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A YAC contig of approximately 3 Mb from human chromosome 5q31-->q33.
    Li X; Wise CA; Le Paslier D; Hawkins AL; Griffin CA; Pittler SJ; Lovett M; Jabs EW
    Genomics; 1994 Feb; 19(3):470-7. PubMed ID: 8188289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma].
    Laureys GG
    Verh K Acad Geneeskd Belg; 1995; 57(5):389-422. PubMed ID: 8571670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics.
    Eisenmann KM; Dykema KJ; Matheson SF; Kent NF; DeWard AD; West RA; Tibes R; Furge KA; Alberts AS
    Oncogene; 2009 Oct; 28(39):3429-41. PubMed ID: 19597464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases.
    Le Beau MM; Espinosa R; Neuman WL; Stock W; Roulston D; Larson RA; Keinanen M; Westbrook CA
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5484-8. PubMed ID: 8516290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cytogenetic delineation of the critical deleted region in the 5q- syndrome.
    Jaju RJ; Boultwood J; Oliver FJ; Kostrzewa M; Fidler C; Parker N; McPherson JD; Morris SW; Müller U; Wainscoat JS; Kearney L
    Genes Chromosomes Cancer; 1998 Jul; 22(3):251-6. PubMed ID: 9624537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears.
    Bigoni R; Cuneo A; Milani R; Cavazzini F; Bardi A; Roberti MG; Agostini P; della Porta M; Specchia G; Rigolin GM; Castoldi G
    Haematologica; 2001 Apr; 86(4):375-81. PubMed ID: 11325642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic loss mapping and physical delineation of a region harboring a putative thymic lymphoma suppressor gene on mouse chromosome 12.
    Shinbo T; Matsuki A; Matsumoto Y; Kosugi S; Takahashi Y; Niwa O; Kominami R
    Oncogene; 1999 Jul; 18(28):4131-6. PubMed ID: 10435594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Deletion of the long arm of chromosome 5 in patients with hematologic malignancies].
    Brezinová J; Zemanová Z; Michalová K
    Cas Lek Cesk; 2001 Feb; 140(2):43-6. PubMed ID: 11262906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and prognostic implications of chromosome 5q deletions: 96 high resolution studied patients.
    Pedersen B; Jensen IM
    Leukemia; 1991 Jul; 5(7):566-73. PubMed ID: 2072742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays.
    Wang L; Fidler C; Nadig N; Giagounidis A; Della Porta MG; Malcovati L; Killick S; Gattermann N; Aul C; Boultwood J; Wainscoat JS
    Haematologica; 2008 Jul; 93(7):994-1000. PubMed ID: 18508791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The putative tumor suppressor gene on chromosome 5q for hepatocellular carcinoma is distinct from the MCC and APC genes.
    Ding SF; Delhanty JD; Dooley JS; Bowles L; Wood CB; Habib NA
    Cancer Detect Prev; 1993; 17(3):405-9. PubMed ID: 8402727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.